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Abstract The health effects of milk and dairy food
consumption would best be determined in randomised
controlled trials. No adequately powered trial has been
reported and none is likely because of the numbers
required. The best evidence comes, therefore, from pro-
spective cohort studies with disease events and death as
outcomes. Medline was searched for prospective studies of
dairy food consumption and incident vascular disease and
Type 2 diabetes, based on representative population sam-
ples. Reports in which evaluation was in incident disease or
death were selected. Meta-analyses of the adjusted esti-
mates of relative risk for disease outcomes in these reports
were conducted. Relevant case–control retrospective stud-
ies were also identiﬁed and the results are summarised in
this article. Meta-analyses suggest a reduction in risk in the
subjects with the highest dairy consumption relative to
those with the lowest intake: 0.87 (0.77, 0.98) for all-cause
deaths, 0.92 (0.80, 0.99) for ischaemic heart disease, 0.79
(0.68, 0.91) for stroke and 0.85 (0.75, 0.96) for incident
diabetes. The number of cohort studies which give evi-
dence on individual dairy food items is very small, but,
again, there is no convincing evidence of harm from con-
sumption of the separate food items. In conclusion, there
appears to be an enormous mis-match between the evi-
dence from long-term prospective studies and perceptions
of harm from the consumption of dairy food items.
Keywords Dairy  Milk  Butter  Cheese  Heart disease 
Stroke  Diabetes  Cohort studies
Introduction
Milk and dairy foods contain saturated fats, and their
consumption often leads to a rise in plasma cholesterol
level. This, together with the belief that milk is ‘fattening’,
appears to have led to the widespread conviction that milk
and dairy foods are a factor in obesity and in heart disease,
and that their consumption should be limited.
At least ten hypotheses have been deﬁned in attempts to
explain the supposed harm from milk and dairy con-
sumption [1]. The mechanism most frequently quoted is,
undoubtedly, a rise in plasma cholesterol concentration
following the ingestion of milk or a dairy food item. The
drawing of conclusions about milk from its effect upon a
single ‘intermediate’ variate, such as cholesterol level, is,
however, quite unreasonable, as it ignores the fact that
milk, being a complex food with a host of nutrients, is
likely to affect many mechanisms relevant to the devel-
opment of vascular and other diseases. The only valid basis
for conclusions about a food item and health or survival
comes from long-term studies of the consumption of that
food and the incidence of disease or death.
Archie Cochrane was one of the ﬁrst to urge that con-
clusions in clinical practice and in medical research are
evidence-based, and that the evidence considered comes
from all of the available, bias-free relevant studies [2]. The
urgings of Cochrane and others have led to ‘evidence-based
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practice.Alvarez-Leo ´netal.[3]have,however,pointedoutthat
statements about the beneﬁts and risks of dairy product con-
sumption appear to be based on selected physio-pathological
data, such as relationships with cholesterol level, and not on
valid epidemiological evidence, indeed, as Alvarez-Leo ´n
et al. commented: ‘‘Public health nutrition should not be
unaware of the need for evidence-based conclusions.’’
The most convincing evidence on a food item and health
would come from randomised controlled trials, but no
adequately powered trials of milk or dairy consumption
have been reported, nor are any likely to be conducted
because of the numbers of participants required and the
compliance that would be necessary from each participant.
By default, the best evidence on dairy food consumption,
health and survival comes, therefore, from long-term
cohort studies with disease events and death as the
outcomes.
We report the results of a literature search and meta-
analyses of prospective cohort studies of milk and dairy
food consumption as predictors, and death, vascular disease
and diabetes as outcomes. We also summarise evidence
from relevant retrospective case–control studies.
Experimental Procedure
As far as possible, the procedures in the review and meta-
analyses which we conducted are those outlined by Egger
et al. [4] and Moher et al. [5] using the statistical pro-
grammes available at http://www.systematicreviews.com.
Search Strategy
A number of searches were conducted using Medline,
PubMed and ISI Web of Science, and four researchers were
involved. Using the search terms for predictors: milk,
dairy, dairy products, cheese, butter, cream and yoghurt,
together with the terms for outcomes: death, heart disease
and stroke, 138 papers were identiﬁed and limiting these to
‘adult’ gave 47 papers. The predictors together with the
outcome terms diabetes and diabetes mellitus Type 2 gave
330 papers. From these, ﬁve papers were selected. Papers
which used a composite of foods including dairy items as a
predictor were not selected. A further three papers with
relevant results, which had not been detected in the elec-
tronic searches but which had been identiﬁed by the lead
author during extensive reading over the past ten and more
years, were included.
In the end, a total of 38 reports of cohort studies were
selected and used in the analyses presented. Five case–
control retrospective studies which gave relevant data
are described in what follows, but are not examined by
meta-analyses. In an attempt to clarify uncertainties, and/or
to obtain further data, letters were sent to 14 authors, but
responses were obtained from only a very few.
Meta-Analyses
The results of a test of homogeneity between studies is
given for each dairy food, together with estimates of the
overall relative risk. Difﬁculties arose from the fact that the
results of individual studies were reported in terms of rel-
ative risk, odds ratio or hazard ratio. These three measures
of risk are not entirely equivalent. However, in almost all
of the studies, the event rate is well below 10% and, in this
situation, the odds ratio can be considered as a good
approximation for the relative risk [4]. The hazard ratio is a
comparison of time-to-event and, so, is not an approxi-
mation for the relative risk. However, repeating the sum-
mary calculations with and without the studies which
reported a hazard ratio produced only a trivial difference in
the results.
The summary statistic was calculated using the ‘meta’
command in the Stata statistical software package [4]. This
uses an inverse-variance weighting to calculate ﬁxed and
random effects summary statistics. The ‘meta’ command
was convenient as it calculates the variance using the con-
ﬁdence intervals of the risk estimate. Homogeneity was
assessed usingtheQstatistic,which teststhenullhypothesis
thatthevariationbetweentrialsiscompatiblewithchance.It
follows a Chi-squared distribution with n - 1 degrees of
freedom, where n is the number of studies being investi-
gated. In many of our groupings, there was signiﬁcant het-
erogeneity. The heterogeneity led to the choice of random
effects models for the summary statistics. The adjusted rel-
ative risks (RR) given in each individual report were noted,
andpooledestimateswereobtainedfromthesebyweighting
the natural logs of each reported RR by the inverse of the
variance, as described by Gao et al. [6].
In addition to all of the above, data from relevant ret-
rospective case–control studies are described in the text.
Results
Dairy Foods
Eight long-term cohort studies have reported on all-cause
deaths in relation to dairy food consumption (Table 1).
Unfortunately, two of the studies [7, 8] do not include
sufﬁcient data for inclusion in a meta-analysis. There is no
signiﬁcant heterogeneity between the results for the six
studies (P = 0.427) and a meta-analysis suggests a small
but signiﬁcant reduction in total mortality in the subjects
with the highest dairy consumption, relative to the risk in
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conﬁdence limits (0.77, 0.98).
Milk
Table 2 summarises data from 11 cohort studies of milk
consumption and ischaemic heart disease (IHD). Again,
two do not include adequate data for inclusion in a meta-
analysis. The results of the other nine cohorts show no
signiﬁcant heterogeneity (P = 0.570) and the overall risk
of incident heart disease in the subjects with the highest
milk intake, relative to those within each cohort with the
lowest milk intakes, is 0.92 (0.80, 0.99).
As indicated in a footnote to Table 2, the result reported
by Hu et al. [9] for whole milk (1.67; 1.14, 1.90) shows
marked heterogeneity with all the other estimates of risk
for milk. We have, therefore, used the estimate of Hu et al.
[9] for skimmed milk in our meta-analysis. If, however, it
is assumed that 20% of women in that cohort had been
drinking whole milk and 80% skimmed milk, then an
overall estimate of IHD risk in the cohort studied by Hu
et al. [9] is 0.96 (0.74, 1.15), and putting this estimate into
Table 1 Dairy foods and all-cause mortality. Details of cohort studies in which the consumption of ‘dairy foods’ (see text) was related to the risk
of death, with an estimate of homogeneity between the studies and the results of a meta-analysis
Study Number in
cohort (length
of follow-up)
Number
of deaths
Factors
adjusted for
Adjusted
estimate
of risk (95% CI)
Predictive factor
and subgroups compared
Kahn et al. [7]
An Adventists
cohort
22,033 subjects
(21 years)
6,075 Age, sex, smoking, history of
vascular disease,
hypertension, diabetes
0.98 (NS) 3? glasses/week vs\1 glass of
whole milk
van der Vijver
et al. [8]
Dutch Civil
Servants cohort
2,605 subjects
(28 years)
Numbers not
stated
Age, smoking, BMI, systolic
BP, cholesterol, energy,
alcohol
1.0 (0.7–1.4)
men
0.8 (0.5–1.3)
women
Top third of total calcium
intake vs lowest third
Kelemen et al.
[45]
Iowa Women’s
cohort
29,017 subjects
(15 years)
3,978 Age, BMI, smoking, energy,
education, hypertension,
post-menopausal, vitamins,
fat intake, fruit, vegetables,
ﬁbre
1.10 (0.97–1.24) A simulation study substituting
a composite of milk, cream,
ice cream yoghurt and cheese
protein
Mann et al. [46]
Oxford Vegetarian
cohort
10,802 subjects
(13.3 years)
383 Age, sex, smoking, social class 0.87 (0.68–1.13) More than 1/2 pint milk/day vs
less than 1/2
Ness et al. [30]
Scottish Men
cohort
5,765 men
(25 years)
2,350 Age, social class, health
behaviour and health status
0.81 (0.61–1.09) 1 pint? milk/day vs no milk
Elwood et al. [31]
Caerphilly cohort
2,512 men
(20–24 years)
811 Age, smoking, social class,
IHD, BMI, energy, alcohol,
fasting cholesterol HDL
cholesterol and triglycerides
1.20 (0.80–1.80) 1 pint? /milk/day vs little or no
milk
Trichopoulou et al.
[47]
A Greek cohort
1,013 diabetic subjects
(4.5 years)
80 Age, gender, smoking,
education weight and height,
hip circum., insulin,
hypertension, hyperchol.,
food groups
0.92 (0.71–1.19) Increase in dairy foods
by 1 SD/day
van der Pols et al.
[48]
Carnegie cohort
4,374 subjects
(66–68 years)
1,468 Age, sex, area, energy, fruit,
vegetables, eggs, protein, fat,
energy
0.77 (0.61–0.98)
a
0.77 (0.61–0.97)
a
Top vs bottom quartile dairy
Top vs bottom quartile milk
Data from Kahn et al. [7] omitted because of the absence of detailed data; van der Vijver et al. [8] omitted because it was based on the total
dietary calcium; Kelemen et al. [45] omitted because it is a test of dietary substitution
0.64M person years; 5,092 deaths: heterogeneity between studies P = 0.427
Meta-analysis (random effects) RR (95% CI) for highest intake groups 0.87 (0.77–0.98)
vs = compared with, or relative to; 1 pint = 0.568 l
a In van der Pols et al. [48], the estimate for dairy intake was included in the above meta-analysis. This is reported as a hazard ratio and if it is
omitted from the meta-analysis, the heterogeneity is P = 0.470 and the overall RR = 0.91 (0.78–1.05)
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123Table 2 Milk and dairy consumption and incident ischaemic heart disease (IHD). Details of cohort studies in which the consumption milk and
dairy foods was related to incident heart disease, with the results of a meta-analysis
Study Number of subjects
(length of
follow-up)
Number of
heart disease
events
Factors adjusted for Adjusted estimate
of risk (95% CI)
Predictive factor
Snowdon et al.
[33]
An Adventists
cohort
8,725 males
15,048 females
(20 years)
758
841
IHD deaths
Age, smoking and other food
items, weight, marital status
0.94
1.11
Two glasses of milk/day vs
none
van der Vijver
et al. [8]
Dutch Civil
Servants
cohort
1,340 males
1,265 females
366
178
CHD deaths
Age, smoking, BMI, systolic
BP, cholesterol, energy,
alcohol
0.77 (0.53–1.11)
0.91 (0.55–1.50)
Top and bottom tertile of
dietary calcium intake
Fraser [49]
An Adventists
cohort
26,473 subjects
(duration not
stated)
Total CHD no.
not stated
None 1.33 (P\0.07) One glass or more whole milk
vs none
Kelemen et al.
[45]
Iowa Women’s
cohort
29,017 subjects
(15 years)
739 CHD
deaths
Age, BMI, smoking, energy,
education, hypertension,
post-menopausal, vitamins,
fat intake, fruit, vegetables,
ﬁbre
1.41 (1.07–1.87) A simulation study substituting
a composite of milk, cream,
ice cream yoghurt and cheese
for protein
Nettleton et al.
[50]
ARIC cohort
14,153 subjects
(13 years)
1,140 incident
heart failure
Age, sex, race, smoking,
alcohol, prevalent disease,
education, activity
1.08 (1.01–1.16)
a High-fat dairy: whole milk,
cheese and ice cream
Shaper et al.
[37]
UK RHS cohort
7,735 subjects
(9.5 years)
608 IHD events Age, social class, smoking,
cholesterol, blood pressure
and diabetes
0.88 (0.55–1.40) Milk drunk and taken on
cereals vs ‘none’
Mann et al. [46]
Oxford
Vegetarian
cohort
10,802 subjects
(13.3 years)
63 IHD deaths Age, sex, smoking, social
class
1.50 (0.81–2.78) More than 1/2 pint milk per
day vs less than 1/2 pint
Bostick et al.
[51]
Iowa women
cohort
34,486 women
(8 years)
387 IHD deaths Age, energy, BMI, waist–hip
ratio, diabetes, smoking, vit.
E, saturated fat, oestrogen,
alcohol, education, activity
0.94 (0.66–1.35) Top and bottom quartile of
milk products
Hu et al. [9]
Health Prof.
cohort
80,082 women
(14 years)
939 total CHD Age, BMI, menopause, HRT,
smoking, alcohol, family
history, hypertension, aspirin,
exercise, vit. E
1.67 (1.14–1.90)
a
0.78 (0.63–0.96)
a
1.04 (0.96–1.12)
a
0.93 (0.85–1.02)
a
More than two glasses milk/
day vs less than one/week:
whole milk, skimmed milk,
one serving per day high-fat
dairy, one serving per day
low-fat dairy
Ness et al. [30]
Scottish Men
cohort
5,765 men
(25 years)
892 CHD
deaths
Age, social class, health
behaviour and health status
0.68 (0.40–1.13) More than one pint milk/day vs
less than one-third/day
Elwood et al.
[31]
Caerphilly
cohort
2,512 men
(20–24 years)
493 total IHD Age, smoking, social class,
IHD, BMI, energy, alcohol,
fasting cholesterol, HDL
cholesterol and triglycerides
0.71 (0.40–1.26) One or more pint/day vs little
or no milk/day
Al Delaimy
et al. [52]
Health Prof.
cohort
39,800 subjects
(12 years)
1,458 total IHD Age, BMI, time period,
smoking, alcohol, energy
and vit E intake, activity,
diabetes, hyperchol, family
history, aspirin
1.03 (0.86–1.26)
1.01 (0.83–1.23)
Top and bottom quintile of
dairy calcium intake
Total dairy product intake
Larmarche [53]
Quebec
Cardiovasc.
Cohort
2,000 men
(13 years)
217 total CHD Age, smoking, BMI, diabetes 0.73 (0.56–0.93) Above and below average
intake of dairy products
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heart disease of 0.91 (0.77–1.07). A similar problem arose
with estimates derived from the same cohort of the US
Nurses Health Study by Sun et al. [10]. They used plasma
pentadecanoic acid as a surrogate for dairy fat consump-
tion, though it can also be obtained from beef, lamb and
venison. The estimate of risk for heart disease that they
obtained is statistically inconsistent with estimates derived
from other populations in which the same surrogate
approach had been used [11]. It could possibly be that the
women within the Nurses’ Cohort who drank whole milk
had become so highly selected with reference to a range of
health-related behaviours that they may have become
unrepresentative of any meaningful population group.
In a report based on 27,529 Adventists, Snowdon [12]
states that milk was not related to all-cause mortality, but
he gives no data. Likewise, Jacobsen and Stensvold [13]
refer to ‘‘a large prospective study with more than 17,000
men and women followed for 11.5 years (which) showed
an inverse relationship between milk drinking (predomi-
nantly full-fat milk) and the risk of cardiovascular death.’’
One of the authors (BKJ) was contacted and details
requested, but these are not now available.
A number of cross-sectional studies have been reported
in which the past milk consumption of patients admitted to
hospital with a myocardial infarct was compared with the
past consumption by control subjects without evidence of
vascular disease. This research strategy has uncertainties
because only a proportion of patients survive an infarct and
are questioned, and because the estimation of milk intake
prior to the infarct is dependent upon memory. Four
such studies have been reviewed elsewhere [14] and a
meta-analysis yielded an overall relative risk of milk
consumption and incident heart disease of 0.83 (0.66,
0.99). A further, unusual case–control study of 144 diabetic
patients with peripheral vascular disease matched with 288
control diabetic patients reported an odds ratio of 0.71
(0.42, 1.19) for peripheral vascular disease in those who
consumed milk more than seven times a week relative to
those who took milk twice or less per week [15].
The estimates of risk for milk consumption and stroke
incidence in the 11 cohorts summarised in Table 3 show
Table 2 continued
Study Number of subjects
(length of
follow-up)
Number of
heart disease
events
Factors adjusted for Adjusted estimate
of risk (95% CI)
Predictive factor
Trichopoulou
et al. [47]
A Greek cohort
1,013 subjects
(4.5 years)
46 CVD deaths Age, gender, smoking,
education, weight and height,
hip circum., insulin,
hypertension, hyperchol.,
food groups
0.95 (0.68–1.31) 150 g (one SD) increase in
dairy products
Umesawa et al.
[54]
JACC cohort
21,068 men
32,319 women
(10 years)
135
99
Total CHD
Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
0.80 (0.45–1.44)
1.06 (0.50–2.25)
Top and bottom quintile
of dairy calcium intake
Umesawa et al.
[32]
JPHC cohort
41,526
(13 years)
322 total CHD Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
1.09 (0.74–1.61) Top and bottom quintile
of dairy calcium intake
van der Pols
et al. [48]
Carnegie
cohort
c
4,374 subjects
(66–68 years)
378 CHD
deaths
Age, sex, area, energy, fruit,
vegetables, eggs, protein, fat,
energy
0.74 (0.45–.22)
a, b
1.06
(0.49 1.31)
a, b
Top and bottom quintile
of dairy products
Top and bottom quintile
of milk
Data from Snowdon et al. [33] and Fraser [49] omitted because of the absence of detailed data; van der Vijver et al. [8] omitted because it was
based on the total dietary calcium; Kelemen et al. [45] omitted because it is a test of dietary substitution; Nettleton et al. [50] omitted because the
outcome is heart failure
4.3M person years; 16,212 IHD events: heterogeneity between studies P = 0.570
Meta-analysis: risk of a heart disease event in the subjects with the highest milk/dairy intake, relative to that in the subjects with the lowest
intake: 0.92 (0.80–0.99)
a If Nettleton et al. [50] is included, the heterogeneity between studies P = 0.033; RR = 0.92 (0.82–1.03)
b An estimate for Hu et al. [9] based on the data for milk, assuming 20% of women had been on whole milk, 80% on skimmed, the heterogeneity
is P = 0.454; overall RR = 0.88 (0.80, 0.97) and when van der Pols et al. is omitted (because an HR is stated), the heterogeneity is P = 0.408;
RR = 0.88 (0.80–0.98). When the estimates of Hu et al. [9] for dairy is used, P = 0.570; RR = 0.92 (0.86–0.99)
c In van der Pols et al. [48], risk estimates which had been adjusted for calcium are not used because the inclusion of calcium may have led to
over-adjustment
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123Table 3 Milk and dairy consumption and incident stroke. Details of cohort studies in which the consumption of milk and dairy foods was related
to incident stroke events, with the results of a meta-analysis
Study Number of subjects
(length of follow-up)
Number and
type of stroke
Factors adjusted for Predictive factor Adjusted
estimate
of risk (95% CI)
Iso et al. [19]
Nurses Health
cohort
85,764 women
(14 years)
347 ischaemic Age, smoking, time interval,
BMI, alcohol, menopause,
hormone use, exercise,
multivitamins, fatty acid
intake, history of hypertension,
diabetes and cholesterol
Top and bottom quintile
of dairy calcium
0.70 (0.51–0.97)
Kinjo et al. [55]
A Japanese
cohort
223,170 subjects
(16 years)
3,084
thromboembolic
Age, sex, area, smoking, alcohol,
occupation
Milk four or more times/
week vs less than once/
week
0.85 (0.77–0.92)
Ness et al. [30]
Scottish Men
cohort
5,765 men
(25 years)
196 stroke deaths Age, social class, health
behaviour and health status
More than one pint/day vs
less than one-third/day
0.84 (0.31–2.30)
Sauvaget et al.
[56]
Life span cohort
40,349 subjects
(16 years)
1,462 stroke
deaths
Sex, age, area, BMI, smoking,
alcohol, education, diabetes,
hypertension, radiation history
Milk almost daily vs none
dairy products almost
daily vs none
0.94 (0.79–1.12)
a
0.73 (0.57–0.94)
He et al. [57]
Health Prof.
cohort
43,732 men
(14 years)
451 ischaemic Smoking, alcohol, BMI, activity,
hyperchol., hypertension,
aspirin, potassium,
multivitamins, vit E, fruit and
veg, energy
High-fat dairy once a
day? vs less than once a
week
1.23 (0.74–2.03)
Elwood et al. [31]
Caerphilly cohort
2,512 men
(22–25 years)
185 ischaemic Age, smoking, social class, IHD,
BMI, energy, alcohol, fasting
cholesterol, HDL cholesterol
and triglycerides
One or more pint/day vs
little or no milk
0.66 (0.24–1.81)
Abbott et al. [58]
Honolulu heart
cohort
3,150 men
(22 years)
229
thromboembolic
Age, dietary K and Na, alcohol,
smoking, activity, BP, glucose,
cholesterol, glucose, uric acid,
Hct
16 oz/day milk drunk vs
non-drinkers
0.67 (0.45–1.00)
Larsson et al. [23]
ATBC cohort
26,556 men
(13.6.years)
2,702 cerebral
infarcts
Age, smoking, alcohol, BMI,
education, total cholesterol,
diabetes, IHD, energy intake
and activity, intake of various
foods and original
randomisation
Top quintile of a
composite of low-fat,
whole and sour milk vs
lowest quintile
1.03 (0.96–1.10)
Umesawa et al.
[54]
JACC cohort
110,792 subjects
(12.9 years)
284 stroke deaths Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
Top and bottom quintile
of dairy calcium intake
0.53 (0.34–0.81)
Umesawa et al.
[32]
JPHC cohort
41,526 subjects
(12.9 years)
664 ischaemic Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
Top and bottom quintile
of dairy calcium intake
0.70 (0.52–0.94)
van der Pols et al.
[48]
Carnegie cohort
4,374 subjects
(66–68 years)
121 stroke deaths Age, sex, area, energy, fruit,
vegetables, eggs, protein, fat,
energy
Top and lowest quartiles
of dairy
Top and bottom quartile
of milk
0.61 (0.27–1.38)
a
0.60 (0.28, 1.33)
8.4M person years; 9,725 strokes: heterogeneity between studies P\0.000
Meta-analysis: risk of a stroke in the subjects with the highest milk/dairy intake, relative to that in the subjects with the lowest intake: 0.79
(0.68–0.91)
a For both Sauvaget et al. [56] and van der Pols et al. [48], the results for ‘dairy’ are used in the meta-analysis
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of risk is signiﬁcant (0.78; 0.68, 0.91), this cannot be
interpreted with conﬁdence. However, the data on stroke in
Table 3 relate, as far as is possible, to ischaemic stroke and
in Table 4, reports on haemorrhagic strokes and sub-
arachnoid bleeds are summarised. Five studies give
evidence on haemorrhagic stroke, and, again, there is sig-
niﬁcant heterogeneity, but the overall risk in relation to
dairy intake is 0.75; (0.60, 0.94). Only three studies give
evidence on sub-arachnoid bleeds and, ignoring signiﬁcant
heterogeneity, the overall risk in those with the highest
dairy intake is 0.65 (0.32, 1.31).
Table 4 Dairy foods, haemorrhagic stroke and sub-arachnoid bleeds.
Details of cohort studies in which the consumption of dairy food was
related to the risk of haemorrhagic stroke, or a sub-arachnoid bleed,
with estimates of homogeneity between the studies and the results of
meta-analyses
Study Number of subjects
(length of follow-
up)
Number and type
of disease event
Factors adjusted for Adjusted RR
(95% CI)
Predictive
factor and subgroups
compared
Kinjo et al.
[55]
A Japanese
cohort
223,170 subjects
(16 years)
4,773 haemorrhagic
stroke deaths
Sex, age, area, smoking,
alcohol, occupation
0.74 (0.68–0.80) Milk four or more times/
week vs once/week
He et al. [57]
Health Prof.
cohort
43,732 men
(14 years)
124 haemorrhagic
strokes
Smoking, alcohol, BMI,
activity, hyperchol.,
hypertension, aspirin,
potassium, multivitamins, vit
E, fruit and veg., energy
1.22 (0.47–3.16) High-fat dairy once a day or
more vs less than once a
week
Umesawa
et al. [54]
JACC cohort
21,068 men
32,319 women
(10 years)
113 haemorrhagic
strokes
128 haemorrhagic
strokes
Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
0.46 (0.23–0.91)
0.51 (0.28–0.94)
Top and bottom quintile of
dairy calcium intake
Umesawa
et al. [32]
JPHC cohort
41,526 subjects
(12.9 years)
425 haemorrhagic
strokes
Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
0.65 (0.43–0.97) Top quintile of dairy calcium
vs lowest quintile
Larsson et al.
[23]
ATBC cohort
26,556 men
(13.6 years)
383 haemorrhagic
strokes
Age, smoking, alcohol, BMI,
education, total cholesterol,
diabetes, IHD, energy intake
and activity, intake of various
foods and original
randomisation
1.01 (0.82–1.20)
a
1.32 (0.89–1.94)
a
Top quintile of a composite
of low-fat, whole and sour
milk vs lowest quintile
Top and lowest quintile of
dairy products vs lowest
quintile
0.36M person years: 5,946 haemorrhagic strokes: heterogeneity between studies P = 0.014
Meta-analysis (random effects) RR (95% CI) for highest intake groups 0.75 (0.60–0.94)
Umesawa
et al. [54]
JACC cohort
21,068 men
32,319 women
(10 years)
37 sub-arachnoid
bleeds
34 sub-arachnoid
bleeds
Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
0.19 (0.04–0.87)
0.41 (0.17–0.97)
Top and bottom quintile of
dairy calcium intake
Umesawa
et al. [32]
JPHC cohort
41,526 subjects
12.9 years
217 sub-arachnoid
bleeds
Age, sex, BMI, smoking,
alcohol, sodium, potassium,
fatty acids, area, menopause,
hyperchol., diabetes
0.74 (0.46–1.61) Top quintile of dairy calcium
vs lowest quintile
Larsson et al.
[23]
ATBC cohort
26,556 men
13.6 years
196 sub-arachnoid
bleeds
Age, smoking, alcohol, BMI,
education, total cholesterol,
diabetes, IHD, energy intake
and activity, intake of various
foods and original
randomisation
1.26 (1.00–1.52) Top and bottom quintile:
dairy products, all milks
(whole ? low-fat ? sour)
0.96M person years: 484 sub-arachnoid bleeds: heterogeneity between studies P = 0.004
Meta-analysis (random effects) RR (95% CI) for highest intake groups 0.65 (0.32–1.31)
vs = compared with, or relative to
a The results for haemorrhagic stroke are based on Larsson et al. [23] for milk. Using Larsson et al. [23] for dairy gives P = 0.022, RR = 0.76
(0.58–1.00)
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Table 5 summarises the data from studies in which butter
and cheese consumption were examined as possible pre-
dictors of vascular disease. For butter, the literature search
identiﬁed only ﬁve cohort studies with incident vascular
disease as the outcome. Only three of these give sufﬁcient
data to enable inclusion in a meta-analysis. The results are
homogeneous, but the overall relationship between butter
consumption and vascular events (0.93; 0.84, 1.02) is not
statistically signiﬁcant. In another early cohort study [16],
832 men were followed for 21 years. There were 267
incident CHD events and the authors commented: ‘butter
intake did not predict CHD incidence,’ but no original data
are given.
Several case–control studies of butter and vascular dis-
ease have been reported. In one, the previous diets of 106
patients with a myocardial infarct were compared with the
diets of 105 controls, and an adjusted odds ratio of an
infarct was reported as 2.80 (1.14, 6.85) for ‘butter and
margarine’ [17]. In another, the use of butter by 287
women with an acute myocardial infarct was compared
with that of 649 control women and an odds ratio in the
upper third, adjusted for age alone, of 2.3 was reported
[18]. In a study of diabetic patients, 144 with peripheral
arterial disease were compared with 288 matched control
patients and an odds ratio of 2.06 (1.15. 3.68) reported for
the consumption of butter [15].
Evidence on cheese and vascular disease is also limited.
Results have been reported from six cohort studies
(Table 5), but sufﬁcient data for a meta-analysis are given
in only two. A difﬁculty arises here because, while random
effects meta-analysis seems to be appropriate throughout
the work in this paper, in the case of the two studies with
cheese, there is a massive difference in the numbers of
events and, hence, in the power of the two studies, with
conclusions in one being based on only 64 vascular events
and on 2,702 disease events in the other. It seems reason-
able, therefore, for this one dairy item, to use a ﬁxed effects
model, thus, weighting the studies appropriately. This gives
an overall estimate of risk from cheese of 0.90 (0.79, 1.03).
Other studies on cheese include a follow-up of 27,529
seventh-day Adventists over 20 years, in which it is stated
that ‘‘…cheese… consumption (was) unrelated to stroke
mortality’’ but no data are given [12]. In a report based on
the 85,764 women in the US Nurses Health Study, the
authors comment that the inverse association observed for
stroke with dairy calcium was not restricted to milk, but
was also observed for hard cheese [19], but, again, no data
are given. Finally, in a wide-ranging review of studies of
cheese consumption, Tholstrup [20] found ‘‘no convincing
evidence of harm,’’ and wrote of the ‘neutral’ effect of
cheese on coronary heart disease.
A number of studies based on retrospective case–control
comparisons examined cheese consumption and vascular
disease. A comparison of the past diets of 106 patients with
myocardial infarction and 105 control subjects [17] gave an
adjusted odds ratio for cheese and yoghurt of 0.42
(0.18–1.03). In another case–control study of 111
myocardial infarction patients and 107 controls [21], an
estimated odds ratio in the highest quartile of cheese intake
of 0.34 (0.13, 0.91) was reported. In yet other case–control
studies, estimates of 0.77 (0.54–1.11) [22] and 1.0 (no CIs
stated) [18] were made for cheese consumption. Finally,
Ciccarone et al. [15] reported an odds ratio for cheese
consumption in 144 diabetic patients with peripheral vas-
cular disease compared with 288 matched control diabetic
patients of 0.61 (0.26–1.45).
Other Dairy Foods
Evidence on other individual dairy food items is very
sparse indeed. The large ATBS cohort of Finnish male
smokers originally enlisted for a randomised trial of anti-
oxidant prophylaxis [23] yielded adjusted odds ratios for
the quintile of subjects with the largest intake of cream
(0.81; 0.72–0.92 for cerebral infarction and 0.72; 0.52–1.00
for intra-cerebral haemorrhage), yoghurt (1.08; 0.95–1.24
and 1.08; 0.58–1.28) and ice cream (0.92; 0.81–1.03 and
1.21; 0.89–1.63), none of which are signiﬁcant. In the
report on the US Nurses Health Study, Iso et al. [19]
commented that the inverse association observed for stroke
with dairy calcium was not restricted to milk, but was also
shown for yoghurt and for ice cream.
Evidence from cross-sectional retrospective studies of
these items comes from Tavani et al. [22], who reported
an odds ratio for yoghurt in a case–control study based on
507 patients with an acute myocardial infarction of 0.55
(0.32–0.95). Biong et al. [21] based a study on 111
myocardial infarction patients and 107 controls and esti-
mated an odds ratio in the highest quartile of ice cream of
0.99 (P = 0.21, no CIs stated). Finally, a case–control
study of cream consumption in 432 diabetic patients
yielded an odds ratio of 2.79 (0.93–8.35) for peripheral
vascular disease [15].
Dairy Foods and Diabetes
Elsewhere [24], we have reported a meta-analysis of cross-
sectional studies of milk and/or dairy consumption and the
metabolic syndrome (RR in the highest consumers of milk
and dairy: 0.74; 0.64–0.84). Five studies have now reported
on dairy consumption and incident Type 2 diabetes
(Table 6). The results of these studies (Table 6) are
homogeneous, and the estimated overall relative risk for
diabetes is 0.85 (0.75–0.96).
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123Table 5 Butter, cheese, and vascular disease and death. Details of cohort studies in which the consumption of cheese and of butter was related to
a disease outcome or death, with estimates of homogeneity between the studies and the results of a meta-analyses
Study Number of subjects
(length of follow-up)
Number and type
of disease event
Factors adjusted for Adjusted estimate
of risk (95% CI)
Predictive factor and
subgroups compared
Kahn et al. [7]
An Adventists cohort
22,033 subjects
(21 years)
5,627 deaths Age, sex, smoking, history of
vascular disease,
hypertension, diabetes
1.03 NS (1) Butter daily cf less
than once/week
Gartside et al. [59]
NHANES I
5,811 (16 years) CHD events
Number not
stated
Age, sex, race, poverty, region,
BMI, smoking, education,
activity, cholesterol
Increase in CHD
events as butter
intake rose
P = 0.026
Use of butter
Shaper et al. [37]
UK RHS cohort
7,735 subjects
(9.5 years)
608 IHD events Age, social class, smoking,
cholesterol, blood pressure
and diabetes
0.87 (0.79–1.06) Use of butter cf
margarine
Elwood et al. reported in
Shaper et al.
Caerphilly cohort
2,187 men
(20–24 years)
605 vascular
events
Age, smoking, social class,
IHD, BMI, alcohol, total fat
intake, systolic BP, diabetes
0.87 (0.69–1.11) Use of butter cf
margarine use
Larsson et al. [23]
ATBC cohort
26,556 men
(13.6 years)
2,702 cerebral
infarcts
383
haemorrhagic
196 sub-
arachnoid
Age, smoking, alcohol, BMI,
education, total cholesterol,
diabetes, IHD, energy intake
and activity, intake of
various foods and original
randomisation
1.00 (0.87–1.14)
a
1.44 (1.01–2.07)
0.98 (0.59–1.64)
Top quintile of butter
cf lowest quintile
Data from Kahn et al. [7] and Gartside et al. [59] omitted because of absence of detailed data
0.36M person years: 3,310 vascular disease events: heterogeneity between studies P = 0.333
Meta-analysis (random effects) RR (95% CI) for highest intake groups 0.93 (0.84–1.02)
Kahn et al. [7]
An Adventists cohort
22,033 subjects (21
years)
6,075 deaths Age, sex, smoking, history of
vascular disease,
hypertension, diabetes
0.96 NS
b Cheese on 5–7 days/
week cf less than
one
Snowdon et al. [33]
An Adventists cohort
25,153 subjects
(20 years)
758 male IHD
deaths
841 female IHD
deaths
Age, smoking and other food
items, weight, marital status
0.95 (P[0.05)
b
0.91 (P[0.05)
b
Cheese daily cf none
Fraser [49]
An Adventists cohort
26,473
(duration not
stated)
Coronary events
Number not
stated
Not stated 0.97 NS Three or more times/
week cf less than
once
Gartside et al. [59]
NHANES I
5,811
(16 years)
CHD events Age, sex, race, poverty, region,
BMI, smoking, education,
activity, cholesterol
0.88 (P\0.002) Once or more/day cf
none
Mann et al. [46]
A vegetarian cohort
10,802 subjects
(13.3 years)
64 IHD deaths Age, sex, smoking, social class 2.47 (0.97–6.26) Cheese 5 or more
times/week cf less
than once
Larsson et al. [23]
ATBC cohort
26,556 men
(13.6 years)
2,702 cerebr.
infarcts
383
haemorrhagic
196 sub-
arachnoid
Age, smoking, alcohol, BMI,
education, total cholesterol,
diabetes, IHD, energy intake
and activity, intake of
various foods and original
randomisation
0.88 (0.77–1.01)
a
1.01 (0.72–1.41)
1.07 (0.66–1.72)
Top quintile of cheese
cf lowest quintile
Data from Kahn et al. [7], Snowdon et al. [33], Fraser [49] and Gartside et al. [59] omitted because ofabsence of detailed data
0.4M person years: 2,766 vascular disease events: heterogeneity between studies P = 0.032
Meta-analysis (random effects) RR (95% CI) for highest intake groups 1.32 (0.49–3.56)
Meta-analysis (ﬁxed effects) RR (95% CI) for highest intake groups 0.90 (0.79–1.03)
cf = compared, or, relative to
a Elwood et al. here represents data from the Caerphilly Cohort Study reported in Shaper et al. [15], re-analysed by us and updated
b The studies of cheese intake by Snowdon et al. [58], by Kahn et al. [7] and by Fraser [23] may be on the same cohort. None of these, nor Gartside et al.
[20], could be included in the meta-analysis, as no estimates of error are given
c For Larsson et al. [10], only the results for cerebral infarction were included in the meta-analysis
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Much has been written on the associations between the
consumption of milk and dairy products and individual
vascular risk factors, and, in particular, effects on plasma
cholesterol level. An evaluation based upon a single risk
factor for a disease can, however, be misleading. At the
same time as affecting lipid markers of heart disease, the
consumption of milk and dairy produce is associated with
an increase in the level of high-density lipoprotein cho-
lesterol [25, 26] and with a reduction in blood pressure [27,
28], and, furthermore, milk and dairy food items are likely
to have effects upon many other biological mechanisms
and disease processes. Even studies which have examined
relationships with a cluster of risk factors for disease, such
as the metabolic syndrome [24], cannot possibly give a
valid estimate of the overall effect of a complex food such
as milk on disease incidence.
Most concern appears to focus on milk consumption
and heart disease, and the evidence we present on this is
substantial. The studies are homogeneous and the meta-
analysis of all of the available evidence suggests that there
is a small but worthwhile reduction in risk of coronary
heart disease (0.92; 0.80, 0.99) in the subjects who drink
the most milk. The evidence which we present on milk and
the risk of stroke is also substantial and suggests a reduc-
tion in both all stroke (0.79; 0.68–0.91) and in haemor-
rhagic lesions in those with the highest consumption
of milk. A reduction in sub-arachnoid haemorrhage was
unexpected, as the aetiology of this condition is totally
different to that of thrombo-embolic or haemorrhagic
stroke, but beneﬁt from a reduction in blood pressure
would be common to all of these events.
All-cause mortality also shows a reduction associated
with dairy food consumption (0.87; 0.77–0.98). The evi-
dence of a reduction in diabetes is also substantial, the
results of the separate studies are homogeneous
(P = 0.122) and the risk reduction in the highest
consumers of dairy foods is statistically signiﬁcant (0.85;
0.75–0.96).
The literature on milk and dairy consumption and cancer
is extensive. A detailed examination of the evidence is
beyond the scope of this review, but it has been reviewed
by the World Cancer Research Fund and the American
Table 6 Milk and dairy consumption and diabetes. Details of cohort studies in which the consumption of milk and dairy foods was related to
new cases of diabetes, with the results of a meta-analysis
Study Number of subjects
(length of follow-up)
Number
of new diabetes
Factors adjusted for Adjusted estimate
of risk (95% CI)
Predictive factor
Choi et al. [60]
Health Prof. Cohort
41,254 males
(12 years)
1,243 Age, smoking, alcohol, energy,
family history, hyperchol.,
hypertension, energy intake
and activity
0.91 (0.85–0.97) Increase of one serving
of dairy foods/day
Liu et al. [61]
Women’s Health cohort
37,183 females
(10 years)
1,603 Age, smoking, alcohol, BMI,
hypertension, hyperchol,
HRT, family history, energy
and activity, dietary intakes
randomisation
0.79 (0.67–0.94)
a
1.04 (0.84–1.30)
0.92 (0.78–1.09)
Top and bottom quintile
of all dairy foods
Whole milk twice?/
week vs\1/month
Skim milk twice?/week
vs\1/month
van Dam et al. [62]
Caerphilly cohort
41,186 females
(8 years)
1,964 Age, BMI, smoking, alcohol,
education, family history,
activity, energy, coffee,
sugar, meat, whole grain
consumption
0.93 (0.75–1.15) Highest vs lowest
quintile of total dairy
intake
Elwood et al. [24]
Caerphilly cohort
640 males
(22–25 years)
41 Age, smoking, social class,
IHD, BMI, alcohol, total fat
intake, systolic BP
0.57 (0.20–1.63) Highest and lowest
quartile of milk intake
Villegas et al. [63]
Shanghai women cohort
64,191 women
(6.9 years)
2,270 Age, BMI, smoking, alcohol,
waist–hip ratio, activity,
income, education,
occupation, hypertension,
energy
0.60 (0.41–0.88) [200 g milk/day vs
none
1.7M person years: 7,121 new diabetic patients: heterogeneity between studies P = 0.122
Meta-analysis (ﬁxed effects) RR (95% CI) for highest intake groups: 0.85 (0.75–0.96)
a The result from Liu et al. [61] for dairy is used in the meta-analysis
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milk or dairy foods is associated with a signiﬁcant reduc-
tion in colon cancer (the pooled RR from ten cohort studies
is 0.78; 0.69–0.88 and for bladder cancer in four cohorts,
the RR is 0.82; 0.67–0.99). There may, however, be an
increased risk of prostate cancer, the relative risk estimated
from eight cohorts being 1.05; 0.98–1.14. No relationship
of importance with milk or dairy consumption was reported
for any other cancer.
Apart, perhaps, from milk, no ﬁrm conclusions can,
however, be drawn on the individual dairy food items. In
fact, there is an extreme paucity of studies relating to
individual dairy food items. We ﬁnd this quite remarkable,
given the strength of the beliefs about the undesirable
effects of butter in particular. The disparity between the
results on butter from cohort and from retrospective case–
control studies is of concern. Thus, the overview of three
cohort studies suggests a possible reduction in vascular
disease risk (0.93; 0.84–1.02), while two cross-sectional
studies suggested an increase and one an increase in
peripheral arterial disease from the consumption of butter.
This kind of inconsistency between evidence collected
prospectively and evidence dependent upon the memory of
patients is, however, not unknown in epidemiological
research, and, perhaps, the main message of these data
relates to the inadequacy of the evidence on butter and the
other dairy items, rather than whether or not there is evi-
dence of harm.
Unfortunately, it is not possible to estimate quantitative
relationships with disease incidence for the consumption of
a dairy item with any conﬁdence. For example, within the
studies reporting milk consumption, the quantity deﬁned as
‘high’ varied in the different studies. Most studies used
quartiles or quintiles of the distribution of intakes, while
others deﬁned milk intake in terms of the number of
occasions on which milk or dairy foods were consumed.
Nevertheless, several studies deﬁned a ‘high’ intake as the
consumption of one pint (568 ml) or more per day [30–32],
in others two or more ‘glasses’ per day [19, 33], while in a
study based on weighed dietary intakes [34], the mean
daily consumption of milk in the subjects who showed a
reduction in vascular disease and diabetes was a pint
(568 ml) or more.
A number of systematic reviews of dairy foods have
already been published and are consistent with what we
present. Gibson et al. [35] identiﬁed 12 cohort studies and,
from them, drew the conclusion that their review showed
‘‘no consistent ﬁndings to support the concept that dairy
food consumption is associated with a higher risk of cor-
onary heart disease.’’ Mente et al. [36] looked at a number
of foods, including milk. Their conclusion, based on ﬁve
cohort studies, was that milk has ‘‘no signiﬁcant associa-
tion with coronary heart disease’’ (0.91; 0.73–1.00). Two
earlier overview studies by us [14, 31] examined associa-
tions with milk, and, although based on smaller numbers of
cohorts, the results of both are in close agreement with
those which we now report.
There are, of course, serious limitations in the evidence
we present. The cohort strategy is powerful, but it still has
uncertainties and possible biases. In particular, estimates of
risk for one item can be confounded by the effects of
dietary and other factors apart from milk and dairy con-
sumption. Then, there are differences in social class,
smoking and other factors between subjects who drink milk
and those who drink little or none, and some of the studies
comment upon these [31, 37]. While all of the estimates
upon which we have based our overall meta-analyses have
each been adjusted for a number of confounding factors, as
listed in the tables (age, social class, smoking, alcohol,
activity etc.), residual confounding by unknown factors is
still possible. While it is possible that this could possibly
explain the observed reductions in vascular disease, dia-
betes and all-cause mortality, it seems highly unlikely that
a true harmful effect of milk/dairy consumption on the
diseases considered could have been missed simply
because of some important, but as yet unknown, con-
founding factor(s). It is also possible, but again extremely
unlikely, that publication bias has led to studies which
showed harm from dairy consumption have been prefer-
entially withheld from publication.
The issue of fat-reduced, skimmed milk and other
fat-reduced dairy products remains. Despite the wide-
spread beliefs that whole milk increases the risk of vas-
cular disease, and is ‘fattening’, the appropriate question to
ask is: do fat-reduced milks provide any advantage further
to the beneﬁts conferred by the consumption of whole
dairy foods or milk, or does the removal of fat reduce the
beneﬁt of the whole items? Low-fat milks were not widely
used in the US until about 1989 and about 2000 in the UK,
and a large part of the follow-up periods of most of the
cohort studies which we have included in the meta-anal-
yses relate, therefore, to times when the milk and dairy
items consumed were the full-fat items. Epidemiological
studies are of necessity long term and, therefore, the data
which we have summarised and the conclusion we have
drawn relate overwhelmingly to whole milk and full-fat
dairy items.
Given the promotion of fat-reduced milks by many
authorities and the large increase in the consumption of
fat-reduced milks and dairy items throughout the Western
world, this is an area requiring critical study. A number of
reports do give evidence on the incidence of disease
events in subjects within the same cohort who drank
whole milk and others who drank fat-reduced milk, and
we have summarised some of these data elsewhere [14].
However, it is most important to accept that persons who
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have adopted other ‘healthy’ behaviours, and these will
confound any differences in disease outcome within
groups of persons deﬁned by the type of milk consumed.
It has to be accepted that these other confounding factors
cannot all be known, but they will be responsible for
biases which cannot possibly be estimated or allowed for.
In the absence of evidence from large long-term ran-
domised trials, the statement of German and Dillard [38]
is, therefore, most apposite: ‘‘Such hypotheses (about fat-
reduced milks) are the basis of sound scientiﬁc debate;
however they are not the basis of sound public health
policy.’’
On a priori grounds, milk would be expected to be
beneﬁcial to health. Calcium has many biological actions,
including a reduction in fat absorption through the forming
of soaps in the intestine and the binding of cholesterol and
bile acids in the gut [39]. Of greater importance is a
reduction of blood pressure by dietary calcium, and in a
6-year study of 2,245 older subjects in the Rotterdam
Cohort Study, a 20% reduction in incident hypertension
was attributed to dairy food consumption [40]. While
calcium, magnesium and potassium are all required to
prevent hypertension, dairy products are unique in pro-
viding a balanced supply of these elements [3, 41]. This
may be why milk appears to have a greater effect on blood
pressure than dietary calcium supplements [27]. Further-
more, in addition to the minerals provided by milk, certain
peptides released on the digestion of milk proteins
may have a beneﬁcial effect on blood pressure by inhibiting
the angiotension-1-converting enzyme, thus, modulating
endothelial function [42].
Renaud et al. [43] described further effects of dietary
calcium on thrombo-embolic mechanisms. They fed butter
to rabbits and to half, they also gave high levels of calcium.
The calcium led to a reduction in platelet aggregation, and
a reduction in the severity of atherosclerosis. However, an
examination of extensive platelet-related tests in 1,433
older men in the Caerphilly Cohort Study [44] gave no
conﬁrmatory evidence in terms of an association between
milk consumption and platelet aggregation to adenosine
phosphate (P = 0.41), or stressed template bleeding times
(P = 0.91) (unpublished data).
The results of the literature search and meta-analyses
presented here are summarised in Table 7 and in Fig. 1.
The similarity of the estimates of risk is remarkable and,
although conclusions have to be tentative, it seems not
unreasonable to conclude that there is no evidence that
dairy foods as a total group are associated with harm to
health either in terms of death, heart disease, stroke or
diabetes, but are probably beneﬁcial in relation to these
disease outcomes.
Apart from their effects on plasma lipids and on blood
pressure, very little is known about the biological mecha-
nisms likely to be involved in the relationships of milk and
dairy foods with human diseases or, indeed, whether milk
can be modiﬁed to provide increased health advantages.
Clearly, more work should be done.
Due to a focus on the small rise in blood cholesterol
with milk drinking, the debate on milk has never achieved
a reasonable balance in the evaluation of risks and beneﬁts.
We believe that the debate about the health risks and
beneﬁts of milk and dairy consumption in Western com-
munities should focus on evidence of direct relevance to
Table 7 Summary of the relative risk for milk and/or dairy food consumption and various diseases, together with the total numbers of deaths in
England and Wales in 2008 from those causes
Cause of death
a Number of cohort
studies (no. in
analyses)
Estimate of the risk ratio
for milk or dairy food
consumption
b (signiﬁcance
of heterogeneity between studies)
Number of deaths
in England and
Wales in 2008
All-cause deaths 8 (5) 0.87; 0.77–0.98 (P = 0.427) 509,090
Ischaemic heart disease (I20–I25)
a 17 (13) 0.92; 0.80–0.99 (P = 0.570) 76,985
Stroke (I60–I69)
a
Thrombo-embolic 11 (11) 0.79; 0.68–0.91 (P\0.000) 46,446
Haemorrhagic 5 (3) 0.75; 0.60–0.94 (P = 0.014) 7,497
Sub-arachnoid 3 (3) 0.65; 0.32–1.31 (P = 0.004) 8,000
c
Type 2 diabetes (E10-15)
a 5 (5) 0.85; 0.75–0.96 (P = 0.122) 5,541
a Causes of death as deﬁned in the short list used in the classiﬁcation of causes of death by the Ofﬁce of National Statistics UK (Ofﬁce for
National Statistics: mortality statistics: cause (series DH2 No.32). London: The Stationery Ofﬁce, 2008)
b Estimate of the risk of each disease in subjects with the highest consumption of milk/dairy, relative to the risk in the subjects with the lowest
risk (usually the top and the bottom ﬁfths in subjects ranked by consumption)
c This is an estimate of the total incidence and not the number of deaths
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review, and this would beneﬁt greatly if it were supported
by a concerted and targeted research effort to understand
the underlying mechanisms.
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